AE hepatic lesions: correlation between calcifications at CT and FDG-PET/CT metabolic activity.


Journal

Infection
ISSN: 1439-0973
Titre abrégé: Infection
Pays: Germany
ID NLM: 0365307

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 11 02 2019
accepted: 23 05 2019
pubmed: 6 6 2019
medline: 7 3 2020
entrez: 6 6 2019
Statut: ppublish

Résumé

To correlate the presence of calcifications in alveolar echinococcosis (AE) hepatic lesions to the metabolic activity in 18 fluorodeoxyglucose positron emission tomography combined with computed tomography (FDG-PET/CT). Our institutional review board approved this study. 61 patients (29 women, 32 men, aged from 15 to 86 years) were included in the study. Images of FDG-PET/CT were interpreted by two independent nuclear medicine physicians. AE hepatic lesions were classified as AE lesions with or without hypermetabolic activity. The presence of calcifications was assessed on unenhanced CT scans by two independent radiologists blinded with regard to the metabolic activity of the AE hepatic lesions. Every single calcification the size of which was < 3 mm and non-measurable calcifications which were forming areas with a powdery appearance were considered as microcalcifications. All other types of calcifications were reported as macrocalcifications. Statistical analysis was performed and p value < 0.05 was considered as statistically significant. Microcalcifications and macrocalcifications were present at CT in 95% (58/61) AE hepatic lesions and 43% (26/61) AE hepatic lesions, respectively. Hypermetabolic activity was present at FDG-PET/CT in 93% (57/61) AE hepatic lesions. 98% (56/57) of the AE hepatic lesions presenting with hypermetabolic activity at FDG-PET/CT showed microcalcifications at CT (p = 0.01) when only 40% (23/57) showed macrocalcifications at CT (p = 0.3). 100% (23/23) of the AE hepatic lesions with hypermetabolic activity at FDG-PET/CT and macrocalcifications at CT showed also microcalcifications at CT. Hypermetabolic activity of AE hepatic lesions at FDG-PET/CT is strongly correlated to the presence of microcalcifications at CT, independently of the presence of macrocalcifications.

Identifiants

pubmed: 31165442
doi: 10.1007/s15010-019-01328-z
pii: 10.1007/s15010-019-01328-z
doi:

Substances chimiques

Radiopharmaceuticals 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

955-960

Références

Int J Exp Pathol. 2000 Dec;81(6):373-90
pubmed: 11298186
Ann Clin Microbiol Antimicrob. 2013 Jan 02;12:1
pubmed: 23281596
PLoS Negl Trop Dis. 2015 Sep 21;9(9):e0003964
pubmed: 26389799
Parasite. 2014;21:69
pubmed: 25526544
Acta Trop. 2010 Apr;114(1):1-16
pubmed: 19931502
J Comput Assist Tomogr. 2018 Mar/Apr;42(2):211-215
pubmed: 29189399
Handb Clin Neurol. 2013;114:65-88
pubmed: 23829901
Acta Trop. 2006 Dec;100(3):163-71
pubmed: 17129569
Abdom Imaging. 2015 Jan;40(1):56-63
pubmed: 24970734
Liver Transpl. 2011 Jul;17(7):855-65
pubmed: 21455928
Nuklearmedizin. 2008;47(4):147-52
pubmed: 18690373
Radiographics. 2012 Nov-Dec;32(7):2053-70
pubmed: 23150858
Med Klin (Munich). 1998 Aug 15;93(8):463-7
pubmed: 9747101
Am J Trop Med Hyg. 2002 Jan;66(1):23-9
pubmed: 12135263
Parasitology. 2003;127 Suppl:S87-107
pubmed: 15027607
World J Gastroenterol. 2016 Apr 7;22(13):3621-31
pubmed: 27053854
J Nucl Med. 2013 Mar;54(3):358-63
pubmed: 23303963
Am J Trop Med Hyg. 1987 May;36(3):576-85
pubmed: 3578654
Parasite. 2014;21:74
pubmed: 25531446
Adv Parasitol. 2017;96:259-369
pubmed: 28212790

Auteurs

Eleonore Brumpt (E)

Service de Radiologie, CHU Besançon, 25000, Besançon, France.

Oleg Blagosklonov (O)

Service de Médecine Nucléaire, CHU Besançon, 250000, Besançon, France.

Paul Calame (P)

Service de Radiologie, CHU Besançon, 25000, Besançon, France.

Solange Bresson-Hadni (S)

WHO Collaborating Center for Prevention and Treatment of Human Echinococcosis, 25000, Besançon, France.

Dominique Angèle Vuitton (DA)

WHO Collaborating Center for Prevention and Treatment of Human Echinococcosis, 25000, Besançon, France.

Eric Delabrousse (E)

Service de Radiologie, CHU Besançon, 25000, Besançon, France. edelabrousse@chu-besancon.fr.
WHO Collaborating Center for Prevention and Treatment of Human Echinococcosis, 25000, Besançon, France. edelabrousse@chu-besancon.fr.
EA 4662 Nanomedicine Lab, Imagery and Therapeutics, Université de Bourgogne Franche-Comté, 25000, Besançon, France. edelabrousse@chu-besancon.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH